Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Reply: budesonide.
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Reply: budesonide.
Bibliographic Details
Main Authors:
Sandborn, W
,
Travis, S
,
Ballard, D
Format:
Journal article
Language:
English
Published:
2013
Holdings
Description
Similar Items
Staff View
Similar Items
Reply
by: Sandborn, W, et al.
Published: (2013)
Budesonide MMX® for the induction of remission of mild to moderate ulcerative colitis: a pooled safety analysis.
by: Lichtenstein, G, et al.
Published: (2015)
Once-daily budesonide MMX® extended-release tablets induce remission in patients with mild to moderate ulcerative colitis: results from the CORE I study.
by: Sandborn, W, et al.
Published: (2012)
Induction of Clinical and Endoscopic Remission of Mild to Moderately Active Ulcerative Colitis With Budesonide MMX (R) 9 mg: Analysis of Pooled Data from Two Phase 3 Studies
by: Sandborn, W, et al.
Published: (2011)
High-dose budesonide for early COVID-19 - Authors' reply
by: Hobbs, FDR, et al.
Published: (2021)